[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

A meta-analysis of bariatric surgery in patients with obesity and polycystic ovary syndrome

Asian J Surg. 2024 Dec;47(12):5083-5087. doi: 10.1016/j.asjsur.2024.04.003. Epub 2024 Apr 18.

Abstract

Polycystic ovary syndrome (PCOS) is a multifactorial disease, which is closely related to obesity. This study evaluated the efficacy of bariatric surgery on obesity complicated with PCOS through meta-analysis. PubMed, Cochrane, EMbase, and WOS databases were searched from 2012 to November 2022. Studies on the efficacy of bariatric surgery in the treatment of obesity combined with PCOS were included. Outcome indicators included menstrual abnormalities, BMI, free testosterone, hypertrichosis, and ovarian volume. Methodological quality of the included studies was evaluated, and statistical analysis was performed using RevMan 5.3 software. Finally, 9 studies were included, and the results of meta-analysis were as follows: After weight loss surgery, menstrual irregularity decreased (RR = -0.83, 95%CI:-1.00∼-0.65, P < 0.00001), and BMI decreased significantly (MD = -13.64, 95%CI:-16.29∼-10.99, P < 0.00001). Free testosterone levels decreased (MD = -22.70, 95 % CI: -36.07 ∼ -9.34, P < 0.00001), the incidence of hypertrichosis decreased (RR = 0.63, 95%CI: 0.45-0.88, p = 0.007 < 0.01), and the ovarian volume decreased (MD = -3.09, 5%CI: -5.76 ∼ -0.42, P < 0.00001).

Keywords: Bariatric surgery; Meta analysis; Obesity; PCOS.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Bariatric Surgery* / methods
  • Body Mass Index
  • Female
  • Humans
  • Obesity* / complications
  • Obesity* / surgery
  • Polycystic Ovary Syndrome* / complications
  • Polycystic Ovary Syndrome* / surgery
  • Testosterone / blood
  • Treatment Outcome

Substances

  • Testosterone